Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Association between oral fluoroquinolone use and retinal detachment.

Pasternak B, Svanström H, Melbye M, Hviid A.

JAMA. 2013 Nov 27;310(20):2184-90. doi: 10.1001/jama.2013.280500.

PMID:
24281462
2.

Oral fluoroquinolones and the incidence of rhegmatogenous retinal detachment and symptomatic retinal breaks: a population-based study.

Kapoor KG, Hodge DO, St Sauver JL, Barkmeier AJ.

Ophthalmology. 2014 Jun;121(6):1269-73. doi: 10.1016/j.ophtha.2013.12.006. Epub 2014 Jan 28.

3.

Oral fluoroquinolones and the risk of retinal detachment.

Etminan M, Forooghian F, Brophy JM, Bird ST, Maberley D.

JAMA. 2012 Apr 4;307(13):1414-9. doi: 10.1001/jama.2012.383.

PMID:
22474205
4.

Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.

Eftekhari K, Ghodasra DH, Haynes K, Chen J, Kempen JH, VanderBeek BL.

Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):745-52. doi: 10.1002/pds.3623. Epub 2014 Apr 22.

5.

Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study.

Inghammar M, Svanström H, Melbye M, Pasternak B, Hviid A.

BMJ. 2016 Feb 26;352:i843. doi: 10.1136/bmj.i843.

6.

An investigation of the potential association between retinal detachment and oral fluoroquinolones: a self-controlled case series study.

Chui CS, Man KK, Cheng CL, Chan EW, Lau WC, Cheng VC, Wong DS, Yang Kao YH, Wong IC.

J Antimicrob Chemother. 2014 Sep;69(9):2563-7. doi: 10.1093/jac/dku145. Epub 2014 May 15.

7.

Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study.

Kuo SC, Chen YT, Lee YT, Fan NW, Chen SJ, Li SY, Liu CJ, Chen TL, Chen TJ, Fung CP.

Clin Infect Dis. 2014 Jan;58(2):197-203. doi: 10.1093/cid/cit708. Epub 2013 Oct 28.

8.

Association between oral fluoroquinolone use and the development of retinal detachment: a systematic review and meta-analysis of observational studies.

Chui CS, Wong IC, Wong LY, Chan EW.

J Antimicrob Chemother. 2015 Apr;70(4):971-8. doi: 10.1093/jac/dku507. Epub 2014 Dec 18. Review.

9.

Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study.

Daneman N, Lu H, Redelmeier DA.

BMJ Open. 2015 Nov 18;5(11):e010077. doi: 10.1136/bmjopen-2015-010077.

10.

Association Between Oral Fluoroquinolone Use and Retinal Detachment.

Raguideau F, Lemaitre M, Dray-Spira R, Zureik M.

JAMA Ophthalmol. 2016 Apr;134(4):415-21. doi: 10.1001/jamaophthalmol.2015.6205.

PMID:
26967005
11.

Exposure to oral fluoroquinolones and the risk of retinal detachment: retrospective analyses of two large healthcare databases.

Fife D, Zhu V, Voss E, Levy-Clarke G, Ryan P.

Drug Saf. 2014 Mar;37(3):171-82. doi: 10.1007/s40264-014-0138-y.

12.

Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.

Lee CC, Lee MT, Chen YS, Lee SH, Chen YS, Chen SC, Chang SC.

JAMA Intern Med. 2015 Nov;175(11):1839-47. doi: 10.1001/jamainternmed.2015.5389.

PMID:
26436523
13.

Oral Fluoroquinolones and the Risk of Uveitis.

Sandhu HS, Brucker AJ, Ma L, VanderBeek BL.

JAMA Ophthalmol. 2016 Jan;134(1):38-43. doi: 10.1001/jamaophthalmol.2015.4092.

PMID:
26512796
14.

Preterm birth and later retinal detachment: a population-based cohort study of more than 3 million children and young adults.

Bonamy AK, Holmström G, Stephansson O, Ludvigsson JF, Cnattingius S.

Ophthalmology. 2013 Nov;120(11):2278-85. doi: 10.1016/j.ophtha.2013.03.035. Epub 2013 May 30. Erratum in: Ophthalmology. 2014 Jan;121(1):433.

PMID:
23726667
15.

Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study.

Sode J, Obel N, Hallas J, Lassen A.

Eur J Clin Pharmacol. 2007 May;63(5):499-503. Epub 2007 Mar 3.

PMID:
17334751
16.

Association between oral fluoroquinolones and retinal detachment.

Albini TA, Karakousis PC, Abbey AM, Bartlett JG, Flynn HW Jr.

Am J Ophthalmol. 2012 Dec;154(6):919-921.e1. doi: 10.1016/j.ajo.2012.09.016. No abstract available.

PMID:
23149367
17.

Risk of acute kidney injury associated with the use of fluoroquinolones.

Bird ST, Etminan M, Brophy JM, Hartzema AG, Delaney JA.

CMAJ. 2013 Jul 9;185(10):E475-82. doi: 10.1503/cmaj.121730. Epub 2013 Jun 3.

18.

[Epidemiology of rhegmatogenous retinal detachment in Beijing, China].

Li X; Study Group Of Epidemiology Of Rhegmatogenous Retinal Detachment In Beijing China.

Zhonghua Yan Ke Za Zhi. 2002 Oct;38(10):584-8. Chinese.

PMID:
12487905
19.

Uveitis risk following oral fluoroquinolone therapy: a nested case-control Study.

Forooghian F, Maberley D, Albiani DA, Kirker AW, Merkur AB, Etminan M.

Ocul Immunol Inflamm. 2013 Oct;21(5):390-3. doi: 10.3109/09273948.2013.808351. Epub 2013 Jul 22.

PMID:
23876164
20.

Expanded criteria for pneumatic retinopexy and potential cost savings.

Goldman DR, Shah CP, Heier JS.

Ophthalmology. 2014 Jan;121(1):318-26. doi: 10.1016/j.ophtha.2013.06.037. Epub 2013 Aug 14.

PMID:
23953099
Items per page

Supplemental Content

Write to the Help Desk